Evogene, Tel Aviv University Advance AI Drug Discovery
REHOVOT & TEL AVIV, Israel, July 8, 2026 Evogene Ltd. and Tel Aviv University’s Blavatnik Center for Drug Discovery...
Biopharmaceuticals
Advertisement
BioLineRx and Hemispherian Report Promising GLIX1 Ovarian Cancer Data
TEL AVIV, Israel & OSLO, Norway, July 8, 2026 BioLineRx Ltd. and Hemispherian AS have announced encouraging new preclinical...
Keenova Reports Positive Phase 3 Results for XIAFLEX
DUBLIN, Ireland, July 8, 2026 Keenova Therapeutics plc has announced positive Phase 3 clinical trial results for XIAFLEX® (collagenase...
Pharvaris Advances Oral HAE Therapy with FDA NDA Acceptance
ZUG, Switzerland, July 6, 2026 Pharvaris announced that the U.S. Food and Drug Administration (FDA) has accepted the New...
Santhera Reports Positive Phase 1 AGAMREE Data
Pratteln, Switzerland, July 1, 2026 Santhera Pharmaceuticals announced positive topline findings from a Phase 1 clinical study of AGAMREE®...
Advertisements
Palisade Bio Receives FDA IND Clearance for PALI-2108
DENVER, Colo., June 29, 2026 Palisade Bio, Inc. announced that the U.S. Food and Drug Administration (FDA) has cleared...
CalciMedica Receives FDA Clearance to Continue Auxora KOURAGE Trial
LA JOLLA, Calif., June 24, 2026 CalciMedica, Inc. announced that the U.S. Food and Drug Administration (FDA) has completed...
SK pharmteco Partners With OTXL to Advance Rare Therapies
RANCHO CORDOVA, Calif., June 18, 2026 SK pharmteco, a leading global contract development and manufacturing organization (CDMO), has announced...
Genentech FDA Filing Advances Lunsumio-Polivy in LBCL
SOUTH SAN FRANCISCO, Calif., June 17, 2026 Genentech, a member of the Roche Group, has reached a significant regulatory...
Mabwell Showcases Strong 9MW2821 Cervical Cancer Data
COPENHAGEN, Denmark, June 18, 2026 Mabwell, an innovation-driven biopharmaceutical company with a fully integrated industry chain, has unveiled encouraging...
Advertisement
